Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03704298
Title Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large B-cell Lymphoma (ZUMA-11)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Kite, A Gilead Company
Indications

B-cell lymphoma

Therapies

axicabtagene ciloleucel + Utomilumab

Cyclophosphamide + Fludarabine

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stanford Cancer Institute Palo Alto California 94305 United States Details
UCLA Hematology/ Oncology Santa Monica California 90404 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Columbia University Medical Center New York New York 10032 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field